Diagnosing melanoma without surgery
Health news update on melanoma skin cancers and a detection device called Melafind.
Melanoma is a deadly skin cancer and usually requires a skin biopsy to make a diagnosis. However, this may soon change as the FDA has just approved a device that can scan the skin.
The device known as Melafind was developed to scan the skin for lesions that have features common in a melanoma. In the past, the only way to make a diagnosis of melanoma has been a biopsy and unfortunately, the majority of these turn out to be negative. Besides producing scars, surgery is also costly and often disfiguring. With Melafind, the dermatologist can rapidly scan the skin and identify early melanotic lesions. If the machine does detect a cancer, then the doctor can go ahead with a biopsy. If the scan does not find any features of a melanoma, it does save the individual unnecessary surgery and money.
MelaFind has been tested in a large prospective study and found to be extremely sensitive in identifying early melanomas.
Melanomas are rare cancers but usually have a lethal outcome when the diagnosis is delayed. According to statistics released by the American Cancer
Society, at least 10,000 people in North America die each year from melanoma and the number of cases are increasing at an exponential rate, especially in young women.
Said Dr Joseph Gulfo, President and CEO of Mela Science “We are extremely pleased with the results of the panel vote and look forward to working with the FDA during its ongoing review of the MelaFind PMA application. Melanoma is virtually 100 percent curable if detected at its earliest stage.”
What remains to be seen is what Melafind scan will cost and how often will be the screening process.
Filed under: Cancer, Featured, Medical Equipment, Skin Health
Comments Off